AAAAAA

   
Results: 1-25 | 26-50 | 51-61
Results: 1-25/61
ZOLMITRIPTAN, A 5-HT1B 1D RECEPTOR AGONIST FOR THE ACUTE ORAL TREATMENT OF MIGRAINE - A MULTICENTER, DOSE-RANGE FINDING STUDY/
Authors: DAHLOF C DIENER HC GOADSBY PJ MASSIOU H OLESEN J SCHOENEN J WILKINSON M SWEET RM KLEIN KB
Citation: C. Dahlof et al., ZOLMITRIPTAN, A 5-HT1B 1D RECEPTOR AGONIST FOR THE ACUTE ORAL TREATMENT OF MIGRAINE - A MULTICENTER, DOSE-RANGE FINDING STUDY/, European journal of neurology, 5(6), 1998, pp. 535-543
EARLY CLINICAL-EXPERIENCE WITH SUBCUTANEOUS NARATRIPTAN IN THE ACUTE TREATMENT OF MIGRAINE - A DOSE-RANGING STUDY
Authors: DAHLOF C HOGENHUIS L OLESEN J PETIT H RIBBAT J SCHOENEN J BOSWELL D FUSEAU E HASSANI H WINTER P
Citation: C. Dahlof et al., EARLY CLINICAL-EXPERIENCE WITH SUBCUTANEOUS NARATRIPTAN IN THE ACUTE TREATMENT OF MIGRAINE - A DOSE-RANGING STUDY, European journal of neurology, 5(5), 1998, pp. 469-477
NEUROIMAGING IN EUROPEAN ACADEMIC NEUROLOGY - PRESENT STATUS AND FUTURE ORGANIZATION
Authors: BARON JC LENZI GL BRUCKE T FRACKOWIAK R HEISS WD PANTANO P PAULSON OB ROSSINI PM SCHOENEN J TOUBOUL PJ VIONDURY J VONKUMMER R
Citation: Jc. Baron et al., NEUROIMAGING IN EUROPEAN ACADEMIC NEUROLOGY - PRESENT STATUS AND FUTURE ORGANIZATION, European journal of neurology, 5(1), 1998, pp. 5-15
CORTICAL ELECTROPHYSIOLOGY IN MIGRAINE AND POSSIBLE PATHOGENETIC IMPLICATIONS
Authors: SCHOENEN J
Citation: J. Schoenen, CORTICAL ELECTROPHYSIOLOGY IN MIGRAINE AND POSSIBLE PATHOGENETIC IMPLICATIONS, Clinical neuroscience, 5(1), 1998, pp. 10-17
INTERICTAL CORTICAL EXCITABILITY IN MIGRAINE - A STUDY USING TRANSCRANIAL MAGNETIC STIMULATION OF MOTOR AND VISUAL CORTICES
Authors: AFRA J MASCIA A GERARD P DENOORDHOUT AM SCHOENEN J
Citation: J. Afra et al., INTERICTAL CORTICAL EXCITABILITY IN MIGRAINE - A STUDY USING TRANSCRANIAL MAGNETIC STIMULATION OF MOTOR AND VISUAL CORTICES, Annals of neurology, 44(2), 1998, pp. 209-215
SPONTANEOUS LONGITUDINALLY ORIENTATED AXONAL REGENERATION IS ASSOCIATED WITH THE SCHWANN-CELL FRAMEWORK WITHIN THE LESION SITE FOLLOWING SPINAL-CORD COMPRESSION INJURY OF THE RAT
Authors: BROOK GA PLATE D FRANZEN R MARTIN D MOONEN G SCHOENEN J SCHMITT AB NOTH J NACIMIENTO W
Citation: Ga. Brook et al., SPONTANEOUS LONGITUDINALLY ORIENTATED AXONAL REGENERATION IS ASSOCIATED WITH THE SCHWANN-CELL FRAMEWORK WITHIN THE LESION SITE FOLLOWING SPINAL-CORD COMPRESSION INJURY OF THE RAT, Journal of neuroscience research, 53(1), 1998, pp. 51-65
EFFECTS OF MACROPHAGE TRANSPLANTATION IN THE INJURED ADULT-RAT SPINAL-CORD - A COMBINED IMMUNOCYTOCHEMICAL AND BIOCHEMICAL-STUDY
Authors: FRANZEN R SCHOENEN J LEPRINCE P JOOSTEN E MOONEN G MARTIN D
Citation: R. Franzen et al., EFFECTS OF MACROPHAGE TRANSPLANTATION IN THE INJURED ADULT-RAT SPINAL-CORD - A COMBINED IMMUNOCYTOCHEMICAL AND BIOCHEMICAL-STUDY, Journal of neuroscience research, 51(3), 1998, pp. 316-327
INTERICTAL POTENTIATION OF PASSIVE ODDBALL AUDITORY EVENT-RELATED POTENTIALS IN MIGRAINE
Authors: WANG W SCHOENEN J
Citation: W. Wang et J. Schoenen, INTERICTAL POTENTIATION OF PASSIVE ODDBALL AUDITORY EVENT-RELATED POTENTIALS IN MIGRAINE, Cephalalgia, 18(5), 1998, pp. 261-265
DOPAMINE AND MIGRAINE - A REVIEW OF PHARMACOLOGICAL, BIOCHEMICAL, NEUROPHYSIOLOGICAL, AND THERAPEUTIC DATA
Authors: MASCIA A AFRA J SCHOENEN J
Citation: A. Mascia et al., DOPAMINE AND MIGRAINE - A REVIEW OF PHARMACOLOGICAL, BIOCHEMICAL, NEUROPHYSIOLOGICAL, AND THERAPEUTIC DATA, Cephalalgia, 18(4), 1998, pp. 174-182
CRANIOMETRIC MEASURES IN CLUSTER HEADACHE PATIENTS
Authors: AFRA J CECCHINI AP SCHOENEN J
Citation: J. Afra et al., CRANIOMETRIC MEASURES IN CLUSTER HEADACHE PATIENTS, Cephalalgia, 18(3), 1998, pp. 143-145
BIOBEHAVIORAL CORRELATES IN MIGRAINE - THE ROLE OF HYPERSENSITIVITY AND INFORMATION-PROCESSING DYSFUNCTION
Authors: GERBER WD SCHOENEN J
Citation: Wd. Gerber et J. Schoenen, BIOBEHAVIORAL CORRELATES IN MIGRAINE - THE ROLE OF HYPERSENSITIVITY AND INFORMATION-PROCESSING DYSFUNCTION, Cephalalgia, 18, 1998, pp. 5-11
NEUROPHYSIOLOGICAL APPROACH TO PRIMARY HEADACHE PATHOPHYSIOLOGY
Authors: LOZZA A CECCHINI AP AFRA J SCHOENEN J
Citation: A. Lozza et al., NEUROPHYSIOLOGICAL APPROACH TO PRIMARY HEADACHE PATHOPHYSIOLOGY, Cephalalgia, 18, 1998, pp. 12-16
CLUSTER HEADACHES - CENTRAL OR PERIPHERAL IN ORIGIN
Authors: SCHOENEN J
Citation: J. Schoenen, CLUSTER HEADACHES - CENTRAL OR PERIPHERAL IN ORIGIN, Lancet, 352(9124), 1998, pp. 253-255
EFFECTIVENESS OF HIGH-DOSE RIBOFLAVIN IN MIGRAINE PROPHYLAXIS - A RANDOMIZED CONTROLLED TRIAL
Authors: SCHOENEN J JACQUY J LENAERTS M
Citation: J. Schoenen et al., EFFECTIVENESS OF HIGH-DOSE RIBOFLAVIN IN MIGRAINE PROPHYLAXIS - A RANDOMIZED CONTROLLED TRIAL, Neurology, 50(2), 1998, pp. 466-470
THE LONG-TERM TOLERABILITY AND EFFICACY OF ORAL ZOLMITRIPTAN (ZOMIG, 311C90) IN THE ACUTE TREATMENT OF MIGRAINE - AN INTERNATIONAL STUDY
Authors: ADELMAN JU BAUMEL B CADY RK BAKER CC COUCH JR DALESSIO DJ DIAMOND S ELKIND AH FOSTER CA GOLDSTEIN J KATZ DA KIRCHNER JR KLAPPER JA KUDROW DB KUNKEL R LANDY SH LICHT JM LINDER SL LODER E MARKLEY HG MATHEW NT MEYER JS NETT R PACKARD RC PERSE T PETERS KS RAMADAN NM RAPOPORT AM ROSING HS SADOWSKY C SAPER JR SHARFMAN MI SILBERSTEIN SD SINGER RP SMITH R SOLOMON G SOLOMON S STARK SR SWANSON JW TAYLOR FR TEPPER SJ TUCHMAN MM VIJAYAN N WALKER J WARD T WARNER JS WENDT JK WINNER P BERAN P BLACK A DONNAN G HERKES G LORD G ZAGAMI A BAUMHACKL U BROUSSALIS T KLINGLER D LADURNER G JACQUY J LOUIS P SCHOENEN J GAWEL MJ HANSEN PE JENSEN K PEDERSEN KK KORSGAARD A LADEMANN A OLESEN J SIMONSEN N SORENSEN PS JENSEN TS TFELTHANSEN P KAASIK AE ZUPPING R FARKKILA M HAANPAA M HAVANKA H HEDMAN C ILMAVIRTA M KINNUNEN E LIUKKONEN J PARTINEN M RAUTAKORPI I REUNANEN M SAKO E SEPPA JM BAREGE M CHAZOT G COLOMBANI JP DUJARDIN M FABRE N GIACOMINO A GERAUD G HENRY P",JOGEIX,"LAPORTE A",LICHTBLAU,"MASSIOU H",MAZINGUEDESAILLY,"MIHOUT B PETIT H VEYRIE M VILAREM H WILMANN JF BECKMANNREINHOLDT A DIENER HC EVERS S GOBEL H KLEPEL H KUHL W LANGOHR HD NEU I PAULUS W PEIKERT A PFAFFENRATH V SCHOLZ E STRAUBE A WITTE OW HARMOUSI S KARAGEORGIOU C MILONAS I GIACOVAZZO M NAPPI G TERBERG JWM SANDERS EACM VANDERZWAN JL EDLAND A ENGELSEN B GRONNING M HALDORSEN T HODNEBO A LARSEN JP DORNZAL T PRUSINSKI A SZCZUDLIK A NAYA MG GRANELL AN LAINEZ JM LEIRA R LIANO H PASCUAL J BOIVIE J DAHLOF C EDVINSSON L HARDEBO JE NILSSON H WALDENLIND E ISLER HR CRAWFORD P DOWSON AJ FINDLEY L GROSS M HAWKES CH JESTICO J ROLAN P STEINER TJ WILKINSON M WAGNER G
Citation: Ju. Adelman et al., THE LONG-TERM TOLERABILITY AND EFFICACY OF ORAL ZOLMITRIPTAN (ZOMIG, 311C90) IN THE ACUTE TREATMENT OF MIGRAINE - AN INTERNATIONAL STUDY, Headache, 38(3), 1998, pp. 173-183
VISUAL-EVOKED POTENTIALS DURING LONG PERIODS OF PATTERN-REVERSAL STIMULATION IN MIGRAINE
Authors: AFRA J CECCHINI AP DEPASQUA V ALBERT A SCHOENEN J
Citation: J. Afra et al., VISUAL-EVOKED POTENTIALS DURING LONG PERIODS OF PATTERN-REVERSAL STIMULATION IN MIGRAINE, Brain, 121, 1998, pp. 233-241
ACUTE MIGRAINE THERAPY - THE NEWER DRUGS
Authors: SCHOENEN J
Citation: J. Schoenen, ACUTE MIGRAINE THERAPY - THE NEWER DRUGS, Current opinion in neurology, 10(3), 1997, pp. 237-243
CLINICAL NEUROPHYSIOLOGY OF HEADACHE
Authors: SCHOENEN J
Citation: J. Schoenen, CLINICAL NEUROPHYSIOLOGY OF HEADACHE, Neurologic clinics, 15(1), 1997, pp. 85
INTENSITY DEPENDENCE OF THE CORTICAL AUDITORY-EVOKED POTENTIALS AS A SURROGATE MARKER OF CENTRAL-NERVOUS-SYSTEM SEROTONIN TRANSMISSION IN MAN - DEMONSTRATION OF A CENTRAL EFFECT FOR THE 5HT(1B 1D) AGONIST ZOLMITRIPTAN (311C90, ZOMIG(R))/
Authors: PROIETTICECCHINI A AFRA J SCHOENEN J
Citation: A. Proietticecchini et al., INTENSITY DEPENDENCE OF THE CORTICAL AUDITORY-EVOKED POTENTIALS AS A SURROGATE MARKER OF CENTRAL-NERVOUS-SYSTEM SEROTONIN TRANSMISSION IN MAN - DEMONSTRATION OF A CENTRAL EFFECT FOR THE 5HT(1B 1D) AGONIST ZOLMITRIPTAN (311C90, ZOMIG(R))/, Cephalalgia, 17(8), 1997, pp. 849-854
ZOLMITRIPTAN (ZOMIG(TM), 311C90), A NOVEL DUAL CENTRAL AND PERIPHERAL5HT(1B 1D) AGONIST - AN OVERVIEW OF EFFICACY/
Authors: SCHOENEN J SAWYER J
Citation: J. Schoenen et J. Sawyer, ZOLMITRIPTAN (ZOMIG(TM), 311C90), A NOVEL DUAL CENTRAL AND PERIPHERAL5HT(1B 1D) AGONIST - AN OVERVIEW OF EFFICACY/, Cephalalgia, 17, 1997, pp. 28-40
FROM GENETICS TO PROPHYLAXIS - DISCUSSION
Authors: DAHLOF C FERRARI M SCHOENEN J EDMEADS J GOADSBY P MASSIOU H
Citation: C. Dahlof et al., FROM GENETICS TO PROPHYLAXIS - DISCUSSION, Cephalalgia, 17, 1997, pp. 4-5
HOW TO DEFINE THE BEST EFFICACY PARAMETERS FOR MIGRAINE - DISCUSSION
Authors: MASSIOU H TFELTHANSEN P GOADSBY P FERRARI M EDMEADS J DAHLOF C SCHOENEN J
Citation: H. Massiou et al., HOW TO DEFINE THE BEST EFFICACY PARAMETERS FOR MIGRAINE - DISCUSSION, Cephalalgia, 17, 1997, pp. 8-9
IS A CENTRAL ACTION OF ACUTE ANTIMIGRAINE DRUGS ESSENTIAL - DISCUSSION
Authors: FERRARI M GOADSBY P SCHOENEN J DAHLOF C EDMEADS J
Citation: M. Ferrari et al., IS A CENTRAL ACTION OF ACUTE ANTIMIGRAINE DRUGS ESSENTIAL - DISCUSSION, Cephalalgia, 17, 1997, pp. 11-11
MEASURING CENTRAL ACTION OF ACUTE ANTIMIGRAINE DRUGS IN HUMANS
Authors: SCHOENEN J
Citation: J. Schoenen, MEASURING CENTRAL ACTION OF ACUTE ANTIMIGRAINE DRUGS IN HUMANS, Cephalalgia, 17, 1997, pp. 12-15
MEASURING CENTRAL ACTION OF ACUTE ANTIMIGRAINE DRUGS IN HUMANS - DISCUSSION
Authors: TFELTHANSEN P SCHOENEN J EDMEADS J DAHLOF C FERRARI M GOADSBY P
Citation: P. Tfelthansen et al., MEASURING CENTRAL ACTION OF ACUTE ANTIMIGRAINE DRUGS IN HUMANS - DISCUSSION, Cephalalgia, 17, 1997, pp. 15-16
Risultati: 1-25 | 26-50 | 51-61